LifeSiteNews.com

Monday December 1, 2008



EU Rejects Patent that “Necessarily Involves the Use and Destruction of Human Embryos”


SHARE: E-mail E-MAIL  Print PRINT     

 By Hilary White

December 1, 2008 (LifeSiteNews.com) – The EU’s patent office has ruled that under the provisions of the European Patent Convention (EPC), it cannot offer a patent for the so-called “WARF/Thomson stem cell application” on the grounds that it would involve the destruction of human embryos. The application is for a method for obtaining embryonic stem cell cultures from primates, including humans, and was filed by the Wisconsin Alumni Research Foundation (WARF) in 1995.

The patent office board of appeal ruled that it is not possible to grant a patent for an invention which necessarily involves the use and destruction of human embryos. The EPC does not allow patenting inventions whose commercial exploitation would be contrary to public order or morality.

Wesley Smith, an American lawyer and writer on bioethics issues, said that the decision is remarkable in that it is the first time there has been an indication from the EU that the moral status of the human embryo is in question.

While a ruling from the patent office does not outlaw the use of embryos in research, Smith writes that it will “send a chill to those who would use embryos commercially.”

“In any event,” Smith wrote, “let us hear no more about religious zealots imposing their will on rational modernists. Europe is as secular a culture as you will find in the world.”

Read related LifeSiteNews.com coverage:

Germany Drops Opposition to EU Embryo Research Funding
http://www.lifesitenews.com/ldn/2006/jul/06072407.html

Back to Top Back to Top

SHARE: E-mail E-MAIL  Print PRINT     



MORE NEWS: LifeSiteNews.com Home Page  Last 10 Days   Archives   Special Reports

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.